| Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis Z Chen, A Bozec, A Ramming, G Schett Nature Reviews Rheumatology 15 (1), 9-17, 2019 | 535 | 2019 |
| Evidence of innate lymphoid cell redundancy in humans F Vély, V Barlogis, B Vallentin, B Neven, C Piperoglou, M Ebbo, T Perchet, ... Nature immunology 17 (11), 1291-1299, 2016 | 318 | 2016 |
| Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells S Rauber, M Luber, S Weber, L Maul, A Soare, T Wohlfahrt, NY Lin, ... Nature medicine 23 (8), 938-944, 2017 | 273 | 2017 |
| SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases D Simon, K Tascilar, F Fagni, G Krönke, A Kleyer, C Meder, R Atreya, ... Annals of the rheumatic diseases 80 (10), 1312-1316, 2021 | 197 | 2021 |
| Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis J Huang, C Beyer, K Palumbo-Zerr, Y Zhang, A Ramming, A Distler, ... Annals of the rheumatic diseases 75 (5), 883-890, 2016 | 187 | 2016 |
| IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin–directed vascular barrier disruption V Langer, E Vivi, D Regensburger, TH Winkler, MJ Waldner, T Rath, ... The Journal of clinical investigation 129 (11), 4691-4707, 2019 | 173 | 2019 |
| PU. 1 controls fibroblast polarization and tissue fibrosis T Wohlfahrt, S Rauber, S Uebe, M Luber, A Soare, A Ekici, S Weber, ... Nature 566 (7744), 344-349, 2019 | 148 | 2019 |
| Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging C Schmidkonz, S Rauber, A Atzinger, R Agarwal, TI Götz, A Soare, ... Annals of the rheumatic diseases 79 (11), 1485-1491, 2020 | 127 | 2020 |
| Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion D Simon, K Tascilar, G Krönke, A Kleyer, MM Zaiss, F Heppt, C Meder, ... Nature communications 11 (1), 3774, 2020 | 104 | 2020 |
| The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis A Zehender, J Huang, AH Györfi, AE Matei, T Trinh-Minh, X Xu, YN Li, ... Nature communications 9 (1), 3259, 2018 | 104 | 2018 |
| Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis A Soare, HA Györfi, AE Matei, C Dees, S Rauber, T Wohlfahrt, CW Chen, ... Arthritis & Rheumatology 72 (1), 137-149, 2020 | 94 | 2020 |
| TGF-β–induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis C Dees, S Pötter, Y Zhang, C Bergmann, X Zhou, M Luber, T Wohlfahrt, ... The Journal of clinical investigation 130 (5), 2347-2363, 2020 | 93 | 2020 |
| Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development A Ramming, D Druzd, J Leipe, H Schulze-Koops, A Skapenko Blood, The Journal of the American Society of Hematology 119 (20), 4665-4674, 2012 | 93 | 2012 |
| Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis T Wohlfahrt, S Usherenko, M Englbrecht, C Dees, S Weber, C Beyer, ... Annals of the rheumatic diseases 75 (3), 623-626, 2016 | 89 | 2016 |
| Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages C Maier, A Ramming, C Bergmann, R Weinkam, N Kittan, G Schett, ... Annals of the rheumatic diseases 76 (6), 1133-1141, 2017 | 86 | 2017 |
| Cutting edge: homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis A Soare, S Weber, L Maul, S Rauber, AM Gheorghiu, M Luber, I Houssni, ... The Journal of Immunology 200 (4), 1249-1254, 2018 | 82 | 2018 |
| Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis N Hannemann, S Cao, D Eriksson, A Schnelzer, J Jordan, M Eberhardt, ... The Journal of clinical investigation 129 (7), 2669-2684, 2019 | 73 | 2019 |
| Group 2 innate lymphoid cells attenuate inflammatory arthritis and protect from bone destruction in mice Y Omata, M Frech, T Primbs, S Lucas, D Andreev, C Scholtysek, K Sarter, ... Cell reports 24 (1), 169-180, 2018 | 73 | 2018 |
| 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study C Bergmann, JHW Distler, C Treutlein, K Tascilar, AT Müller, A Atzinger, ... The Lancet Rheumatology 3 (3), e185-e194, 2021 | 60 | 2021 |
| The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis C Bergmann, A Brandt, B Merlevede, L Hallenberger, C Dees, T Wohlfahrt, ... Annals of the rheumatic diseases 77 (1), 150-158, 2018 | 60 | 2018 |
